inositol has been researched along with Ventricular Dysfunction, Left in 4 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Inositols were administered as mixture of myo-inositol and d-chiro-inositol in the drinking water." | 5.56 | Myo-inositol and d-chiro-inositol oral supplementation ameliorate cardiac dysfunction and remodeling in a mouse model of diet-induced obesity. ( Di Lascio, N; Faita, F; Forini, F; Kusmic, C; L'Abbate, S; Marchetti, S; Nicolini, G, 2020) |
| "Inositols were administered as mixture of myo-inositol and d-chiro-inositol in the drinking water." | 1.56 | Myo-inositol and d-chiro-inositol oral supplementation ameliorate cardiac dysfunction and remodeling in a mouse model of diet-induced obesity. ( Di Lascio, N; Faita, F; Forini, F; Kusmic, C; L'Abbate, S; Marchetti, S; Nicolini, G, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| L'Abbate, S | 1 |
| Nicolini, G | 1 |
| Forini, F | 1 |
| Marchetti, S | 1 |
| Di Lascio, N | 1 |
| Faita, F | 1 |
| Kusmic, C | 1 |
| Oe, H | 1 |
| Nakamura, K | 1 |
| Kihara, H | 1 |
| Shimada, K | 1 |
| Fukuda, S | 1 |
| Takagi, T | 1 |
| Miyoshi, T | 1 |
| Hirata, K | 1 |
| Yoshikawa, J | 1 |
| Ito, H | 1 |
| Liao, Y | 1 |
| Takashima, S | 1 |
| Zhao, H | 1 |
| Asano, Y | 1 |
| Shintani, Y | 1 |
| Minamino, T | 1 |
| Kim, J | 1 |
| Fujita, M | 1 |
| Hori, M | 1 |
| Kitakaze, M | 1 |
| Lee, CW | 1 |
| Lee, JH | 1 |
| Lim, TH | 1 |
| Yang, HS | 1 |
| Hong, MK | 1 |
| Song, JK | 1 |
| Park, SW | 1 |
| Park, SJ | 1 |
| Kim, JJ | 1 |
2 trials available for inositol and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Comparison of effects of sitagliptin and voglibose on left ventricular diastolic dysfunction in patients with type 2 diabetes: results of the 3D trial.
Topics: Aged; Diabetes Mellitus, Type 2; Diastole; Dipeptidyl-Peptidase IV Inhibitors; Echocardiography; Fem | 2015 |
Prognostic significance of cerebral metabolic abnormalities in patients with congestive heart failure.
Topics: Adult; Aspartic Acid; Brain; Brain Diseases, Metabolic; Choline; Creatine; Female; Follow-Up Studies | 2001 |
2 other studies available for inositol and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Myo-inositol and d-chiro-inositol oral supplementation ameliorate cardiac dysfunction and remodeling in a mouse model of diet-induced obesity.
Topics: Action Potentials; Administration, Oral; Animals; Arrhythmias, Cardiac; Diet, High-Fat; Dietary Supp | 2020 |
Control of plasma glucose with alpha-glucosidase inhibitor attenuates oxidative stress and slows the progression of heart failure in mice.
Topics: Acetophenones; Animals; Blotting, Western; Body Weight; Cells, Cultured; Disease Progression; Echoca | 2006 |